(Q39553561)

13 September 2017

title

Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells (English)

1 reference

13 September 2017

0 references

1 reference

Jun-Min Li

1

1 reference

13 September 2017

Yan Yang

2

1 reference

13 September 2017

Ping Zhu

3

1 reference

13 September 2017

Fang Zheng

4

1 reference

13 September 2017

Fei-Li Gong

5

1 reference

13 September 2017

Yuan-Wu Mei

6

1 reference

13 September 2017

language of work or name

1 reference

26 April 2011

1 reference

Immunopharmacology and Immunotoxicology

13 September 2017

published in

1 reference

13 September 2017

volume

34

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

36-41

1 reference

Mechanisms of mitoxantrone in multiple sclerosis--what is known?

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Mitoxantrone (novantrone): a review of experimental and early clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Mitoxantrone and cytotoxic drugs' mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Evaluation of mitoxantrone for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Therapeutic role of mitoxantrone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Therapeutic effect of anthracene-based anticancer agent ethonafide in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Improving MS patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Heterogeneity and plasticity of T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.572890

10.3109/08923973.2011.572890

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference